Jove
Visualize
Contact Us

Related Experiment Videos

Extra pyramidal side effects associated with paroxetine.

S D Nicholson1

  • 1Psychiatric Department, North Devon District Hospital, Raleigh Park.

West of England Medical Journal
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anorexia nervosa in later life: an overview.

Hospital medicine (London, England : 1998)·1998
Same author

Patients who (need to) tell stories.

British journal of hospital medicine·1994
Same journal

Cooking the Books.

West of England medical journal·2017
Same journal

Why I like Chest Physicians.

West of England medical journal·2017
Same journal

Which Journal?

West of England medical journal·2017
Same journal

Physicians for Human Rights (UK).

West of England medical journal·2017
Same journal

Professional Society.

West of England medical journal·2017
Same journal

Unauthorized Version.

West of England medical journal·2017
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Severe extra-pyramidal side effects occurred in a patient treated with paroxetine after trifluoperazine. These side effects resolved upon medication withdrawal, marking a potential new adverse reaction to paroxetine.

Area of Science:

  • Psychiatry
  • Clinical Pharmacology
  • Neuroscience

Background:

  • Paranoid psychosis is a serious mental health condition requiring effective pharmacotherapy.
  • Trifluoperazine is a typical antipsychotic medication used for managing psychotic disorders.
  • Paroxetine is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for depression and anxiety.

Observation:

  • A patient with paranoid psychosis initially responded well to trifluoperazine treatment.
  • Upon reducing trifluoperazine dosage and adding paroxetine, the patient experienced severe extra-pyramidal side effects.
  • These adverse effects subsided after discontinuing all psychotropic medications and did not reappear when trifluoperazine was restarted.

Findings:

  • This case report details the first instance of severe extra-pyramidal side effects potentially linked to paroxetine administration in a patient with paranoid psychosis.

Related Experiment Videos

  • The findings suggest a possible interaction or direct effect of paroxetine contributing to these neurological adverse events.

    • Implications:

    • Clinicians should be vigilant for extra-pyramidal side effects when prescribing paroxetine, especially in patients with a history of antipsychotic use.
    • Further research is warranted to elucidate the mechanism underlying paroxetine-induced extra-pyramidal symptoms and its potential interaction with antipsychotics.
    • This case highlights the importance of careful medication management and monitoring for adverse drug reactions in psychiatric patients.